Holen Sie sich die Stockscreener-App
17.77
6.47%
-1.23
Handel nachbörslich:
17.77
Schlusskurs vom Vortag:
$19.00
Offen:
$19
24-Stunden-Volumen:
839.04K
Relative Volume:
1.58
Marktkapitalisierung:
$4.85B
Einnahmen:
$1.18B
Nettoeinkommen (Verlust:
$132.61M
KGV:
29.80
EPS:
0.5964
Netto-Cashflow:
$-276.17M
1W Leistung:
-16.53%
1M Leistung:
-3.00%
6M Leistung:
-14.20%
1J Leistung:
-34.65%
1-Tages-Spanne:
$17.49
$19.38
1-Wochen-Bereich:
$17.49
$22.07
52-Wochen-Spanne:
$16.56
$34.73
Stevanato Group Spa Stock (STVN) Company Profile
Vergleichen Sie STVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| STVN | 17.77 | 4.85B | 1.18B | 132.61M | -276.17M | 0.5964 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-22 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-11-01 | Herabstufung | Jefferies | Buy → Hold |
| 2023-09-26 | Eingeleitet | Stephens | Overweight |
| 2023-09-19 | Eingeleitet | CJS Securities | Market Outperform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | Eingeleitet | BofA Securities | Buy |
| 2021-08-10 | Eingeleitet | Citigroup | Buy |
| 2021-08-10 | Eingeleitet | Jefferies | Buy |
| 2021-08-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-10 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Stevanato Group Spa Aktie (STVN) Neueste Nachrichten
Objective long/short (STVN) Report - Stock Traders Daily
Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com
Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com
Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com
Pharmaceutical Visual Inspection Systems Market Report: - openPR
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance
Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian
Stevanato Group to Present at Three Major Healthcare Investor Conferences in Q4 | STVN Stock News - StockTitan
Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group
Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com
Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St
Medical devices assembly lines - Stevanato Group
Stevanato Group S.p.A. (NYSE:STVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Citi maintains buy on Stevanato Group with $28 target - Investing.com India
Earnings call: Stevanato Group reports modest growth, eyes future recovery - Investing.com
Stevanato Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Customized in-vitro diagnostic consumable - Stevanato Group
In-Vitro Diagnostics (IVD) and Medical Solutions - Stevanato Group
Secondary packaging lines for the pharma industry - Stevanato Group
Drug Delivery systems and solutions - Stevanato Group
Stevanato Group Q3 2024 Earnings Overview - TipRanks
Citi maintains buy on Stevanato Group with $28 target By Investing.com - Investing.com UK
Stevanato Group SpA earnings missed by €0.02, revenue topped estimates - Investing.com
Stevanato Group (STVN) Q3 Earnings Match Estimates - Yahoo Canada Finance
Stevanato: Q3 Earnings Snapshot - San Antonio Express-News
Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian
Stevanato Group S.P.A. Provides Earnings Guidance for the Full Year 2024 - Marketscreener.com
(STVN) Trading Signals - Stock Traders Daily
What's Next: Stevanato Gr's Earnings Preview - Benzinga
Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
(STVN) On The My Stocks Page - Stock Traders Daily
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt - Simply Wall St
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 - Business Wire
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers - Smartkarma
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Squarepoint Ops LLC Purchases 6,853 Shares of Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Pharmaceutical Visual Inspection Systems Market: Detailed - openPR
The Manufacturers Life Insurance Company Boosts Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Check Out Stevanato Group Spa (STVN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Financial Fitness Check: Examining Stevanato Group Spa (STVN)’s Key Ratios - The Dwinnex
Stevanato Group Spa (STVN)’s stock price in review: A technical analysis - US Post News
Stevanato Group Introduces Large-Volume Vertiva On-Body Delivery System - Contract Pharma
Stevanato Group Spa (STVN) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Market Recap Check: Stevanato Group Spa (STVN)’s Negative Finish at 20.00, Up/Down -6.24 - The Dwinnex
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan - StockTitan
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors? - Insider Monkey
Sei Investments Co. Trims Stake in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Finanzdaten der Stevanato Group Spa-Aktie (STVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):